Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 4.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.25 | - |
NAV | ₹292.74 | - |
Fund Started | 01 Aug 2005 | - |
Fund Size | ₹1096.95 Cr | - |
Exit Load | Exit load of 1% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
4.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.25
-
NAV
₹292.74
-
Fund Started
01 Aug 2005
-
Fund Size
₹1096.95 Cr
-
Exit Load
Exit load of 1% if redeemed within 30 days.
-
Returns
1 Year | 1.31% | - |
3 Year | 24.52% | - |
5 Year | 17.10% | - |
1 Year
1.31%
-
3 Year
24.52%
-
5 Year
17.10%
-
Holding Analysis
Equity | 98.98% | - |
Cash | 1.02% | - |
Equity
98.98%
-
Cash
1.02%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.61% |
Ajanta Pharma Ltd. | 5.48% |
Cipla Ltd. | 5.48% |
Lupin Ltd. | 4.70% |
Procter & Gamble Health Ltd. | 3.99% |
Glenmark Pharmaceuticals Ltd. | 3.74% |
Dr. Reddy's Laboratories Ltd. | 3.74% |
Gland Pharma Ltd. | 3.62% |
Apollo Hospitals Enterprise Ltd. | 3.58% |
Alkem Laboratories Ltd. | 3.56% |
-
Fund Manager
Name | Kamal Gada | - |
Start Date | 02 May 2022 | - |
Name
Kamal Gada
-
Start Date
02 May 2022
-
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | - |
Launch Date | 01 Aug 2005 | - |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
-
Launch Date
01 Aug 2005
-